Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Antimicrobial Resistance and Infection Control|November 30, 2022
Carbapenem-resistant Pseudomonas aeruginosa: an assessment of frequency of isolation from ICU versus non-ICU, phenotypic and genotypic profiles in a multinational population of hospitalized patientsChristian M Gill, David P Nicolau, The Journal of Antimicrobial Chemotherapy|November 21, 2022
Phenotypic and genotypic profile of ceftolozane/tazobactam-non-susceptible, carbapenem-resistant Pseudomonas aeruginosaChristian M Gill, David P Nicolau, Clinical Therapeutics|January 2, 2023
Piperacillin/Tazobactam Dose Optimization in the Setting of Piperacillin/Tazobactam-susceptible, Carbapenem-resistant Pseudomonas aeruginosa: Time to Reconsider Susceptible Dose DependentChristian M Gill, David P Nicolau, Current Opinion in Infectious Diseases|October 1, 2019
Pharmacologic optimization of antibiotics for Gram-negative infectionsChristian M Gill, David P NicolauAntimicrobial Agents and Chemotherapy|April 6, 2023
In Vivo Pharmacodynamic Profile of EVER206, a Novel Polymyxin Antimicrobial, against Gram-Negative Bacteria in the Murine Thigh Infection ModelChristian M Gill, David P NicolauHospital Pharmacy|November 15, 2024
Assessment of the Workflow and Time to Antibiotic Dose Adjustment for Critically Ill Patients Starting Continuous Renal Replacement TherapyMegan Fulbright, Robert Sbertoli, Christian M GillPathogens (Basel, Switzerland)|June 25, 2025
Implications of Intravenous and Inhaled Amikacin Breakpoint Reporting for Mycobacterium avium Complex Pulmonary IsolatesChristian M Gill, Robin Chamberland, Getahun AbateThe Journal of Antimicrobial Chemotherapy|December 28, 2023
In vitro activity of cefiderocol against a global collection of carbapenem-resistant Pseudomonas aeruginosa with a high level of carbapenemase diversityChristian M Gill, Debora Santini, David P Nicolau, et al.Microbiology Spectrum|October 23, 2025
In vitro persistence of clinical methicillin-resistant Staphylococcus aureus isolates from bone and joint infections after exposure to daptomycin, telavancin, and vancomycinAliaa Fouad, Joseph L Kuti, Christian M GillThe Journal of Antimicrobial Chemotherapy|January 13, 2021
In vivo activity of WCK 4282 (high-dose cefepime/tazobactam) against serine β-lactamase-producing Enterobacterales and Pseudomonas aeruginosa in the neutropenic murine thigh infection modelChristian M Gill, Kamilia Abdelraouf, David P NicolauPageof 6